X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2548) 2548
Publication (287) 287
Book Chapter (61) 61
Book Review (36) 36
Book / eBook (14) 14
Dissertation (9) 9
Conference Proceeding (5) 5
Magazine Article (5) 5
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cannabidiol (1831) 1831
index medicus (1059) 1059
humans (958) 958
animals (906) 906
male (743) 743
cannabinoids (738) 738
pharmacology & pharmacy (695) 695
cannabidiol - pharmacology (665) 665
cannabis (516) 516
neurosciences (455) 455
marijuana (444) 444
mice (440) 440
tetrahydrocannabinol (385) 385
rats (365) 365
female (339) 339
cannabidiol - therapeutic use (304) 304
clinical neurology (299) 299
dronabinol - pharmacology (293) 293
psychiatry (279) 279
cannabinoids - pharmacology (266) 266
delta-9-tetrahydrocannabinol (255) 255
delta-tetrahydrocannabinol (241) 241
endocannabinoid system (217) 217
analysis (215) 215
dose-response relationship, drug (213) 213
adult (208) 208
pharmacology (208) 208
epilepsy (205) 205
thc (195) 195
cannabidiol - administration & dosage (190) 190
cannabinoid (189) 189
drug combinations (176) 176
anandamide (153) 153
multiple sclerosis (145) 145
disease models, animal (142) 142
cannabinoids - therapeutic use (137) 137
medical marijuana (135) 135
middle aged (134) 134
biochemistry & molecular biology (133) 133
receptors (133) 133
anxiety (132) 132
cbd (132) 132
dronabinol (132) 132
inflammation (132) 132
health aspects (131) 131
neurology (130) 130
cannabis - chemistry (129) 129
schizophrenia (126) 126
receptor (123) 123
brain (121) 121
cannabinoid receptor (121) 121
treatment outcome (121) 121
expression (120) 120
pain (119) 119
cannabinoid receptors (118) 118
double-blind (118) 118
research (118) 118
care and treatment (117) 117
time factors (117) 117
seizures (116) 116
dronabinol - therapeutic use (112) 112
endocannabinoids (110) 110
in-vitro (110) 110
oxidative stress (108) 108
plant extracts - therapeutic use (107) 107
activation (106) 106
article (106) 106
multiple sclerosis - drug therapy (105) 105
dronabinol - administration & dosage (104) 104
multiple-sclerosis (104) 104
spasticity (100) 100
rats, wistar (98) 98
drug therapy (97) 97
cannabinol (96) 96
drug interactions (95) 95
inhibition (94) 94
dronabinol - analogs & derivatives (93) 93
psychosis (89) 89
muscle spasticity - drug therapy (88) 88
neuroprotection (87) 87
behavioral sciences (86) 86
cancer (86) 86
cb1 (86) 86
double-blind method (86) 86
drugs (85) 85
mental disorders (85) 85
rat (85) 85
apoptosis (84) 84
usage (84) 84
δ9-tetrahydrocannabinol (84) 84
adolescent (83) 83
cannabidiol - analysis (83) 83
brain - drug effects (82) 82
cannabidiol - adverse effects (82) 82
dronabinol - analysis (82) 82
young adult (82) 82
pharmacokinetics (80) 80
sativex (80) 80
cannabidiol - metabolism (79) 79
clinical trials (79) 79
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2521) 2521
German (30) 30
French (16) 16
Spanish (14) 14
Japanese (12) 12
Chinese (9) 9
Portuguese (8) 8
Hungarian (4) 4
Danish (3) 3
Polish (3) 3
Italian (2) 2
Norwegian (2) 2
Korean (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in Pharmacological Sciences, ISSN 0165-6147, 2016, Volume 38, Issue 3, pp. 198 - 201
Once a widely ignored phytocannabinoid, cannabidiol now attracts great therapeutic interest, especially in epilepsy and cancer. As with many rising trends,... 
Advanced Basic Science | PHARMACOLOGY & PHARMACY | DELTA-9-TETRAHYDROCANNABINOL | THC | Cannabis - chemistry | Humans | Cannabidiol - pharmacology | Cannabidiol - therapeutic use | Cannabis - metabolism | Cannabidiol - metabolism | Cannabidiol - chemistry
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 04/2019, Volume 368, pp. 63 - 71
Cannabidiol (CBD) is a natural compound with psychoactive therapeutic properties well described. Conversely, the immunological effects of CBD are still poorly... 
Cannabidiol | DHM-Cannabidiol | Macrophages | TNF | NF-kB
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 04/2019, Volume 368, pp. 63 - 71
Cannabidiol (CBD) is a natural compound with psychoactive therapeutic properties well described. Conversely, the immunological effects of CBD are still poorly... 
Cannabidiol | DHM-Cannabidiol | Macrophages | TNF | NF-kB
Journal Article
NEUROPHARMACOLOGY, ISSN 0028-3908, 08/2013, Volume 71, pp. 282 - 291
The mechanisms underlying the neuroprotective effects of cannabidiol (CBD) were studied in vivo using a hypoxic-ischemic (HI) brain injury model in newborn... 
Pigs | Brain | Neuroprotection | ACTIVATION | Serotonin | PIGLET | Cannabidiol | REPERFUSION | BLOOD-FLOW | NEUROSCIENCES | ENCEPHALOPATHY | HETEROMERS | Cannabinoids | IN-VITRO | Newborn | TARGETS | PHARMACOLOGY & PHARMACY | CEREBRAL-ISCHEMIA | Hypoxia-ischemia | Neuroprotective Agents - therapeutic use | Neurons - pathology | Serotonin 5-HT1 Receptor Antagonists - pharmacology | Humans | Neuroprotective Agents - antagonists & inhibitors | Protein Multimerization | Receptor, Serotonin, 5-HT1A - genetics | Male | Cannabidiol - antagonists & inhibitors | Hypoxia-Ischemia, Brain - pathology | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Brain Injuries - physiopathology | Receptor, Cannabinoid, CB2 - genetics | Recombinant Fusion Proteins - metabolism | Brain - metabolism | Cannabinoids - pharmacokinetics | Hypoxia-Ischemia, Brain - etiology | Neuroprotective Agents - pharmacology | Neuroprotective Agents - pharmacokinetics | HEK293 Cells | Cannabinoid Receptor Antagonists - pharmacology | Cannabidiol - pharmacokinetics | Cannabidiol - therapeutic use | Neurons - metabolism | Neurons - drug effects | Cannabinoids - metabolism | Hypoxia-Ischemia, Brain - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | Disease Models, Animal | Animals, Newborn | Nerve Tissue Proteins - antagonists & inhibitors | Hypoxia-Ischemia, Brain - drug therapy | Neurons - immunology | Cannabidiol - pharmacology | Random Allocation | Brain - drug effects | Nerve Tissue Proteins - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Cannabinoids - therapeutic use | Animals | Receptor, Serotonin, 5-HT1A - chemistry | Reperfusion Injury - prevention & control | Brain - pathology | Brain - immunology | Sus scrofa
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2016, Volume 15, Issue 3, pp. 270 - 278
Journal Article
Journal of Pain and Symptom Management, ISSN 0885-3924, 2010, Volume 39, Issue 2, pp. 167 - 179
Journal Article
EUROPEAN JOURNAL OF PHARMACOLOGY, ISSN 0014-2999, 03/2012, Volume 678, Issue 1-3, pp. 78 - 85
Journal Article
Journal Article